While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
CNN5d
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.
AOL5d
Weight-loss drug competition heats up with growing pill market
The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk (NVO) and Eli Lilly (LLY) by introducing GLP-1 pills.
The New York Times5d
The Weight Loss Hacks That Claim to Work Like Ozempic
Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze. By Dani Blum There’s a long list of products that companies and influencers ...
Yahoo6d
Once-a-day weight loss pill shows promise in trial
A new weight loss pill developed by the maker of Ozempic and Wegovy helped overweight and obese people lose up to 13% of ...
Diabetes.co.uk3d
New diet pill may help people lose more weight than popular injections
A daily diet pill has shown promising results in early trials, with participants losing an average of 13% of their body weight in 12 weeks compared to 6% in those taking the Wegovy injection.
Novo Nordisk Shares Drop Nearly 5% on Disappointing Obesity Pill Data
LONDON/COPENHAGEN (Reuters) -Novo Nordisk's shares fell nearly 5% on Friday after results from a Phase 2a trial of the Danish ...
STAT1d
Novo’s new obesity drug shows modest results, raises concerns of psychiatric side effects
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...